References
- Irwin DJ, Trojanowski JQ, Grossman M. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer’s disease. Front Aging Neurosci. 2013;5:1–11.
- Bonner MF, Ash S, Grossman M. The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants. Curr Neurol Neurosci Rep. 2010;10:484–90.
- Butts AM, Machulda MM, Duffy JR, Strand EA, Whitwell JL, Josephs KA. Neuropsychological profiles differ among the three variants of primary progressive aphasia. J Int Neuropsychol Soc. 2015;21:429–35.
- Ratnavelli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.
- Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
- Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
- Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530–4.
- Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology. 2003;60:1094–7.
- Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, et al. Frontotemporal lobar degeneration: Demographic characteristics of 353 patients. Arch Neurol. 2005;62:925–30.
- Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
- Blasco H, Guennoc AM, Veyrat-Durebex C, Gordon PH, Andres CR, Camu W, et al. Amyotrophic lateral sclerosis: A hormonal condition? Amyotroph Lateral Scler. 2012;13:585–8.
- McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–70.
- Williams JR, Fitzhenry D, Grant L, Martyn D, Kerr DA. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. BMC Neurol. 2013;13:160.
- Burrell JR, Vucic S, Kiernan MC. Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:283–9.
- Anderer P, Saletu B, Gruber D, Linzmayer L, Semlitsch HV, Saletu-Zyhlarz G, et al. Age-related cognitive decline in the menopause: Effects of hormone replacement therapy on cognitive event-related potentials. Maturitas. 2005;51:254–69.
- Hammond R, Gibbs RB. GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance. Brain Res. 2011;1379:53–60.
- Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels. Maturitas. 1993;17:23–9.
- Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin N Am. 2003;87:1065–76.
- Johann S, Beyer C. Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J Steroid Biochem Mol Biol. 2013;137:71–81.
- Grossman M, Anderson C, Khan A, Avants B, Elman L, McClusky L. Impaired action knowledge in amyotrophic lateral sclerosis. Neurology. 2008;71:1396–401.
- Libon DJ, Xie SX, Moore P, Farmer J, Antani S, McCawley G, et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurology. 2007;68:369–75.
- Cook PA, McMillan CT, Avants BB, Peelle JE, Gee JC, Grossman M. Relating brain anatomy and cognitive ability using a multivariate multimodal framework. NeuroImage. 2014;99:477–86.
- Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14:167–77.
- Bolla KI, Lindgren KN, Bonaccorsy C, Bleeker ML. Predictors of verbal fluency (FAS) in the healthy elderly. J Clin Psychol. 1990;46:623–8.
- Crossley M, D’Arcy C, Rawson NSB. Letter and category fluency in community-dwelling Canadian seniors: A comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol. 1997;19:52–62.
- Lanting S, Haugrud N, Crossley M. The effect of age and sex on clustering and switching during speeded verbal fluency tasks. J Int Neuropsychol Soc. 2009;15:196–204.
- Brickman AM, Paul RH, Cohen RA, Williams LM, MacGregor KL, Jefferson AL, et al. Category and letter verbal fluency across the adult lifespan: Relationship to EEG theta power. Arch Clin Neuropsychol. 2005;20:561–73.
- Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review. Front Neuroendocrinol. 2008;29:88–113.
- Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: Findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013;98:3829–38.
- Griksiene R, Ruksenas O. Effects of hormonal contraceptives on mental rotation and verbal fluency. Psychoneuroendocrinology. 2011;36:1239–48.
- Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 1998;50:368–73.
- Murguia Rice M, Borenstein Graves A, McCurry S, Gibbons L, Bowen J, Wayne C, et al. Post-menopausal estrogen and estrogen progestin use and 2-year rate of cognitive change in a cohort of Japanese American women. Arch Inter Med. 2000;160: 1640–9.
- Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging. 2000;21:373–83.
- Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. jama. 1999;281:1197–202.
- Flaherty-Craig C, Brothers A, Dearman B, et al. Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS. Amyotroph Lateral Scler. 2009;10:107–12.
- Lagarde J, Valabregue R, Corvol J-C, Garcin B, Volle E, Le Ber I, et al. Why do patients with neurodegenerative frontal syndrome fail to answer: ‘In what way are an orange and a banana alike?’ Brain. 2015;135:456–71.
- Bocchetta M, Cardosa MJ, Cash DM, Ourselin S, Warren JD, Rohrer JD. Patterns of regional cerebellar atrophy in genetic frontotemporal dementia. NeuroImage Clin. 2016;11:287–90.
- Satoh J, Yamomoto Y, Kitano S, Takitani M, Asahina M, Kino Y. Molecular network analysis suggests a logiclahypothesis for the patholoigcla role of C9orf72 in Anyotrophis Lateral Sclerosis/Frontotemporal Dementia. J Cen Nerv Sys Dis. 2014;6:69–78.
- Flaherty-Craig C, Brothers A, McFalls A, Yang C, Simmons Z. VALUES: A national multicenter study of regional and gender differences in frontotemporal dementia in amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2012;2:325–36.
- Flaherty C, Brothers A, Hoffer D, Harrison M, Yang C, Legro RS, Simmons Z. VALUES: A national multicenter study demonstrating gender differences in amyotrophic lateral sclerosis with behavioral impairment. Neurodegener Dis Manag. 2013;3:515–24.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scl Other Motor Neuron Disord. 2000;1:293–9.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
- Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: Findings from the randomized, controlled KEEPS- Cognitive and Affective Study. PLoS Med. 2015;12:1–25.
- Kiernan RJ, Mueller J, Langston JW, vanDyke C. The Neurobehavioral Cognitive Status Examination- A brief but differentiated approach to cognitive assessment. Ann Intern Med. 1987;107:481–5.
- Wilkinson GS, Roberson GJ, Wide Range Achievement Test 4 professional manual. 2006; Lutz, FL: Psychological Assessment Resources
- Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: Demographic corrections for age, education and ethnicity. Assessment. 1999;6:147–78.
- Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734–47.
- Crawford JR, Stewart LE, Cochrane RHB, Parker DM, Besson JAO. Construct validity of the national adult reading test: A factor analytic study. Pers Individ Dif. 1989;10:585–7.
- Kertesz A, Davidson W, Fox H. Frontal Behavioral Inventory: Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.
- Cortellaro M, Nencioni T, Boschetti C, Ortolani S, Buzzi F, Francucci B, et al. Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment. Eur J Clin Pharmacol. 1991;41:555–9.
- Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology. 2011;76:1886–93.
- Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis: a longitudinal study in 52 patients. J Neurol. 2005;252:772–81.
- Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology. 1999;53:1665–70.
- Bak TH, Hodges JR. The effects of motor neurone disease on language: Further evidence. Brain Lang. 2004;89:354–61.
- Meier S, Charleston A, Tippett L. Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain. 2010;133:3444–57.
- Habas C, Kamdar N, Nguyen D, Prater K, Beckmann CF, Menon V, et al. Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci. 2009;29:8586–94.
- Grossman M, Smith EE, Koenig P, Glosser G, DeVita C, Moore P, McMillan C. The neural basis for categorization in semantic memory. NeuroImage. 2002;17:1549–61.
- Guo CC, Tan R, Hodges JR, Hu X, Sami S, Hornberger M. Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia. Brain. 2016;139:1527–38.
- Tan R, Devenney E, Dobson-Stone C, Kwok J, Hodges J, Kiernan M, et al. Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum. Plos One. 2014;9:1–10.
- Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J. Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology. 2008;71:736–42.
- Liu M, Kelley MH, Herson PS, Hurn PD. Neuroprotection of sex steroids. Minerva Endocrinol. 2010;35:127–43.